The global fibrin sealants market is poised for significant growth, driven by advancements in surgical procedures and the increasing prevalence of chronic diseases. Valued at $550 million in 2022, the Fibrin Sealant Market is projected to reach $1.1 billion by 2032, exhibiting a CAGR of 7.8% from 2023 to 2032.
Fibrin sealants are hemostatic agents used to control bleeding during surgical procedures. They mimic the final stages of the coagulation cascade, forming a fibrin clot that aids in tissue sealing and wound healing. These sealants are fully degraded by the body’s natural processes, making them a preferred choice in various surgical specialties.
Get Sample PDF Copy Here: https://www.alliedmarketresearch.com/request-sample/A31579
Fibrin Sealant Market Growth Factors
Several factors contribute to the growth of the fibrin sealants market:
- Increase in Surgical Procedures: The rise in general, cardiovascular, orthopedic, and ophthalmic surgeries boosts the demand for fibrin sealants. For instance, in the U.S., an estimated 278,000 bariatric surgeries were performed in 2019.
- Aging Population: The global increase in the geriatric population, who are more susceptible to chronic diseases, leads to a higher number of surgeries, thereby driving market growth.
- Technological Advancements: Innovations in fibrin sealant products, such as the launch of plasma protein-based VISTASEAL by Grifols in 2019, enhance the effectiveness and application of these sealants.
- Resumption of Elective Surgeries: Post-COVID-19, the resumption of postponed surgeries has increased the demand for fibrin sealants in procedures related to orthopedic diseases, cardiovascular diseases, and ophthalmic conditions.
Fibrin Sealant Market Segmentation
The fibrin sealants market is segmented based on dosage form, application, end user, and region.
By Dosage Form
- Patch: Held the largest market share in 2022 due to its high adoption in reducing blood loss and wound management.
- Liquid: Includes frozen and freeze-dried fibrin sealants, widely used in various surgical procedures.
- Powder: Used in specific applications where liquid or patch forms are less effective.
By Application
- Others: This segment, including dental surgeries, cosmetic surgery, and pulmonary diseases, held the largest share in 2022.
- General Surgery: A significant application area due to the broad use of fibrin sealants in various procedures.
- Cardiovascular Surgery: A critical area where fibrin sealants help in controlling bleeding and enhancing surgical outcomes.
- Wound Management: Growing importance in managing surgical and traumatic wounds.
- Orthopedic Surgery: Increasing use in joint and bone surgeries to reduce bleeding and promote healing.
- Urological and Ophthalmic Surgeries: Specialized applications where fibrin sealants aid in tissue sealing and hemostasis.
By End User
- Hospitals: Dominated the market in 2022 due to the high volume of surgical procedures and availability of advanced medical facilities.
- Ambulatory Surgical Centers: Growing adoption of fibrin sealants in outpatient surgical procedures.
- Clinics: Use of fibrin sealants in minor surgical procedures and wound management.
By Region
- North America: Held the largest market share in 2022, attributed to the high number of chronic heart disease cases, advanced healthcare infrastructure, and presence of key market players.
- Europe: Significant market due to the increasing number of surgical procedures and aging population.
- Asia-Pacific: Expected to witness notable growth owing to the rise in geriatric population, unmet medical demands, and increased healthcare investments.
- LAMEA: Emerging market with potential growth opportunities due to improving healthcare infrastructure.
Key Players in the Fibrin Sealant Market
The fibrin sealants market features several key players contributing to its growth:
- Baxter International Inc.
- Becton, Dickinson and Company
- Corza Medical
- CSL Behring
- Grifols, S.A.
- Hemarus Therapeutics Ltd.
- Johnson & Johnson
- Nordson Corporation (Nordson Medical)
- Shanghai RAAS Blood Products Co., Ltd.
- Vivostat A/S
These companies are engaged in strategies such as product launches, collaborations, and acquisitions to strengthen their market position.
The fibrin sealants market is on a robust growth trajectory, driven by the increasing number of surgical procedures, technological advancements, and rising prevalence of chronic diseases. With significant opportunities in emerging economies and continuous innovation by key players, the market is expected to expand substantially by 2032.
Procure Complete Report: https://www.alliedmarketresearch.com/fibrin-sealants-market/purchase-options
Thanks for reading this article; AMR also offers Custom Research services providing focused, comprehensive and tailored research according to clientele objectives. Thanks for reading this article; you can also get individual chapter wise sections or region wise reports like North America, Europe, or Asia.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
